Opterion Health Announces Positive Phase 1 Results for OPT101, Supporting Advancement to Phase 2a

Phase 1positiveOPT101Positive

AI Analysis

Summary

Opterion Health announced positive Phase 1 results for OPT101, a non-glucose approach to peritoneal dialysis treatment, supporting progression to Phase 2a clinical trials.

Clinical Trial Data

Phase

Phase 1

Primary Endpoint

Met

Outcome Details

Phase 1 results support advancement to Phase 2a

Importance:6/10

Sentiment:

0.75

Phase 1positive resultsOPT101peritoneal dialysisadvancement to Phase 2a

Related Companies

$GLUC

Read the original article

Published by GlobeNewswire Clinical Studies on September 22, 2026 6:15 AM

Read Original